Clinical Trial Update: Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of biphasic insulin aspart formulations 50 and 70 in Japanese healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 50 (insulin aspart, biphasic 50/50)
• Biphasic insulin aspart 70 (insulin aspart, biphasic 70/30)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED